IP Library Granted Patent US 8,853,165
Granted Patent B2
US 8,853,165 · App. 13/821,811 · Granted Oct 7, 2014

Peptide having the ability to regenerate bone tissue and for binding to apatite

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,853,165
App. No.
13/821,811
Granted
Oct 7, 2014
Kind
B2
Abstract

The present invention relates to a peptide having bone tissue regeneration capacity and binding to a surface of apatite. More particularly, a peptide is provided having bone tissue regeneration capacity and specifically binding to a surface of apatite mineral, capable of being stably immobilized to the surface of apatite mineral to retain effective activity and exhibit bone regeneration effects for a long time, by linking an amino acid sequence having bone tissue regeneration capacity and an amino acid sequence having apatite-binding capacity to each other to thereby provide a peptide having both bone-forming effects and binding capacity to the surface of apatite mineral. A composition for bone tissue regeneration containing the peptide is further provided.

Claims (22)

1. An isolated peptide having bone tissue regeneration capacity and binding to apatite, in which one peptide of amino acid sequence SEQ ID NO: 35 and one peptide of amino acid sequence SEQ ID NO: 36 are linked to each other.

2. A bone graft material in which the peptide of claim 1 is immobilized on a surface of apatite.

3. The bone graft material of claim 2 , wherein the apatite is selected from the group consisting of organism-derived hydroxyapatite bone minerals, synthetic hydroxyapatite, carbonated apatite, tricalcium phosphate, and monocalcium phosphate.

4. The bone graft material of claim 2 , wherein the peptide is contained in a content of 1˜100 mg per unit weight (1 g) of the bone graft material.

5. A biomaterial for bone regeneration, in which the peptide of claim 1 is immobilized on a surface of apatite.

6. The biomaterial for bone regeneration of claim 5 , wherein the biomaterial is selected from the group consisting of metals, natural polymers, and synthetic polymers.

7. The biomaterial for bone regeneration of claim 5 , wherein the apatite is selected from the group consisting of organism-derived hydroxyapatite bone minerals, synthetic hydroxyapatite, carbonated apatite, tricalcium phosphate, and monocalcium phosphate.

8. The biomaterial for bone regeneration of claim 5 , wherein the peptide is contained in a content of 1˜100 mg per unit weight (1 g) of the biomaterial for bone regeneration.

9. A method for bone tissue regeneration, the method comprising the step of grafting the peptide according to claim 1 into a recipient site.

10. A method for bone tissue regeneration, the method comprising the step of grafting a composition containing the peptide according to claim 1 into a recipient site.

11. The method for bone tissue regeneration of claim 10 , wherein the composition is a bone graft material or a biomaterial for bone regeneration.

12. An isolated peptide having bone tissue regeneration capacity and binding to apatite, wherein the peptide is represented by the amino acid sequence of SEQ ID NO: 40.

13. A bone graft material in which the peptide of claim 12 is immobilized on a surface of apatite.

14. The bone graft material of claim 13 , wherein the apatite is selected from the group consisting of organism-derived hydroxyapatite bone minerals, synthetic hydroxyapatite, carbonated apatite, tricalcium phosphate, and monocalcium phosphate.

15. The bone graft material of claim 13 , wherein the peptide is contained in a content of 1˜100 mg per unit weight (1 g) of the bone graft material.

16. A biomaterial for bone regeneration, in which the peptide of claim 12 is immobilized on a surface of apatite.

17. The biomaterial for bone regeneration of claim 16 , wherein the biomaterial is selected from the group consisting of metals, natural polymers, and synthetic polymers.

18. The biomaterial for bone regeneration of claim 16 , wherein the apatite is selected from the group consisting of organism-derived hydroxyapatite bone minerals, synthetic hydroxyapatite, carbonated apatite, tricalcium phosphate, and monocalcium phosphate.

19. The biomaterial for bone regeneration of claim 16 , wherein the peptide is contained in a content of 1˜100 mg per unit weight (1 g) of the biomaterial for bone regeneration.

20. A method for bone tissue regeneration, the method comprising the step of grafting the peptide according to claim 15 into a recipient site.

21. A method for bone tissue regeneration, the method comprising the step of grafting a composition containing the peptide according to claim 12 into a recipient site.

22. The method for bone tissue regeneration of claim 21 , wherein the composition is a bone graft material or a biomaterial for bone regeneration.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Jan 31, 2018
From: NH EXPANSION CREDIT FUND HOLDINGS LP
To: ETHERTRONICS, INC.
Reel/Frame 045210/0725 →
SECURITY INTEREST Recorded Oct 21, 2016
From: ETHERTRONICS, INC.
To: NH EXPANSION CREDIT FUND HOLDINGS LP
Reel/Frame 040464/0245 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 28, 2013
From: CHUNG, CHONG-PYOUNG; PARK, YOON-JEONG; RHEE, SANG HOON; LEE, JUE-YEON
To: NANO INTELLIGENT BIOMEDICAL ENGINEERING CORPORATION CO., LTD.
Reel/Frame 030493/0236 →